Huadong Medicine Past Earnings Performance
Past criteria checks 4/6
Huadong Medicine's earnings have been declining at an average annual rate of -0.8%, while the Healthcare industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 4.1% per year. Huadong Medicine's return on equity is 13.1%, and it has net margins of 7.2%.
Key information
-0.8%
Earnings growth rate
-0.8%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 4.1% |
| Return on equity | 13.1% |
| Net Margin | 7.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Huadong Medicine makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 40,920 | 2,946 | 8,028 | 1,287 |
| 31 Dec 23 | 40,624 | 2,839 | 8,091 | 1,271 |
| 30 Sep 23 | 40,251 | 2,707 | 7,928 | 1,069 |
| 30 Jun 23 | 39,902 | 2,592 | 7,817 | 1,008 |
| 31 Mar 23 | 38,897 | 2,550 | 7,889 | 962 |
| 01 Jan 23 | 37,715 | 2,499 | 7,652 | 1,016 |
| 30 Sep 22 | 36,494 | 2,388 | 7,104 | 1,040 |
| 30 Jun 22 | 35,582 | 2,342 | 6,758 | 1,109 |
| 31 Mar 22 | 34,599 | 2,248 | 6,443 | 1,079 |
| 01 Jan 22 | 34,563 | 2,302 | 6,633 | 980 |
| 30 Sep 21 | 34,110 | 2,324 | 6,675 | 964 |
| 30 Jun 21 | 34,202 | 2,389 | 6,898 | 885 |
| 31 Mar 21 | 33,982 | 2,431 | 6,810 | 883 |
| 31 Dec 20 | 33,683 | 2,820 | 6,992 | 927 |
| 30 Sep 20 | 33,319 | 2,991 | 6,891 | 1,051 |
| 30 Jun 20 | 33,858 | 2,948 | 6,923 | 1,084 |
| 31 Mar 20 | 34,339 | 3,053 | 6,964 | 1,179 |
| 31 Dec 19 | 35,446 | 2,813 | 6,921 | 1,073 |
| 30 Sep 19 | 35,087 | 2,671 | 6,615 | 952 |
| 30 Jun 19 | 33,587 | 2,570 | 6,092 | 911 |
| 31 Mar 19 | 32,532 | 2,515 | 5,706 | 771 |
| 31 Dec 18 | 30,663 | 2,267 | 5,132 | 706 |
| 30 Sep 18 | 29,585 | 2,099 | 4,978 | 652 |
| 30 Jun 18 | 29,066 | 2,031 | 4,690 | 726 |
| 31 Mar 18 | 28,519 | 1,895 | 4,554 | 555 |
| 31 Dec 17 | 27,832 | 1,780 | 4,359 | 462 |
| 30 Sep 17 | 27,911 | 1,740 | 4,298 | 276 |
| 30 Jun 17 | 27,227 | 1,665 | 4,371 | 0 |
| 31 Mar 17 | 26,363 | 1,556 | 4,254 | 0 |
| 31 Dec 16 | 25,380 | 1,447 | 4,096 | 0 |
| 30 Sep 16 | 24,491 | 1,365 | 4,074 | 0 |
| 30 Jun 16 | 23,588 | 1,253 | 3,978 | 0 |
| 31 Mar 16 | 22,682 | 1,188 | 3,749 | 0 |
| 31 Dec 15 | 21,727 | 1,097 | 3,512 | 0 |
| 30 Sep 15 | 20,923 | 1,136 | 3,292 | 0 |
| 30 Jun 15 | 20,220 | 1,034 | 3,067 | 0 |
| 31 Mar 15 | 19,656 | 899 | 2,997 | 0 |
| 31 Dec 14 | 18,947 | 757 | 2,772 | 0 |
| 30 Sep 14 | 18,208 | 655 | 2,672 | 0 |
| 30 Jun 14 | 17,724 | 631 | 2,520 | 0 |
| 31 Mar 14 | 17,237 | 617 | 2,395 | 0 |
| 31 Dec 13 | 16,718 | 575 | 2,267 | 0 |
| 30 Sep 13 | 16,202 | 560 | 2,114 | 0 |
| 30 Jun 13 | 15,638 | 549 | 2,047 | 0 |
Quality Earnings: 000963 has high quality earnings.
Growing Profit Margin: 000963's current net profit margins (7.2%) are higher than last year (6.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 000963's earnings have declined by 0.8% per year over the past 5 years.
Accelerating Growth: 000963's earnings growth over the past year (15.5%) exceeds its 5-year average (-0.8% per year).
Earnings vs Industry: 000963 earnings growth over the past year (15.5%) exceeded the Healthcare industry -2.6%.
Return on Equity
High ROE: 000963's Return on Equity (13.1%) is considered low.